← 返回

病毒逃逸 NK 细胞介导的免疫监视:对肿瘤免疫治疗的启示?

英文原题:Viral escape from NK-cell-mediated immunosurveillance: A lesson for cancer immunotherapy?

查看英文原题

Viral escape from NK-cell-mediated immunosurveillance: A lesson for cancer immunotherapy?

PubMed 2023/08/12(内容时间) Eur J Immunol Q2 · IF 4.1(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

自然杀伤(NK)细胞是参与针对病毒感染细胞和肿瘤免疫应答的固有淋巴细胞。作为对抗手段,病毒和肿瘤采用策略逃逸NK细胞介导的免疫监视。在这篇综述中,我们探讨病毒采用的免疫逃逸策略,重点关注人CMV和严重急性呼吸综合征冠状病毒2的实例。我们探讨选定的病毒逃逸机制,将其分为三类:(1)为抑制性受体NKG2A提供配体,(2)下调活化性受体NKG2D的配体,(3)诱导免疫抑制性细胞因子转化生长因子(TGF)-。对于每一类,我们将病毒与肿瘤的免疫逃逸进行类比,综述在癌症治疗中克服逃逸的潜在机会。我们认为,深入研究病毒与NK细胞之间的宿主-病原体相互作用,不仅会加深我们对病毒免疫逃逸的理解,还将揭示NK细胞如何对抗此类逃逸尝试。因此,由于病毒与肿瘤免疫逃逸的相似性,我们提出,从抗病毒NK细胞应答中获得的见解可作为宝贵的经验,用于设计未来的癌症免疫疗法。

展开英文摘要原文

Natural killer (NK) cells are innate lymphocytes that participate in immune responses against virus-infected cells and tumors. As a countermeasure, viruses and tumors employ strategies to evade NK-cell-mediated immunosurveillance. In this review, we examine immune evasion strategies employed by viruses, focusing on examples from human CMV and severe acute respiratory syndrome coronavirus 2.

We explore selected viral evasion mechanisms categorized into three classes: (1) providing ligands for the inhibitory receptor NKG2A, (2) downregulating ligands for the activating receptor NKG2D, and (3) inducing the immunosuppressive cytokine transforming growth factor (TGF)- . For each class, we draw parallels between immune evasion by viruses and tumors, reviewing potential opportunities for overcoming evasion in cancer therapy.

We suggest that in-depth investigations of host-pathogen interactions between viruses and NK cells will not only deepen our understanding of viral immune evasion but also shed light on how NK cells counter such evasion attempts.

Thus, due to the parallels of immune evasion by viruses and tumors, we propose that insights gained from antiviral NK-cell responses may serve as valuable lessons that can be leveraged for designing future cancer immunotherapies.

论文信息

作者
Momayyezi P、Bilev E、Ljunggren HG、Hammer Q
单位
Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Huddinge, Stockholm, Sweden.Sweden
文献类型
综述 · 非美国政府资助研究
期刊
European journal of immunology2023 Nov
原文标识
PubMed 37526136 · DOI 10.1002/eji.202350465